About us

PanTera, based in Mol, is a joint venture between SCK CEN and IBA. We are building a facility for the production of the radioisotope Actinium-225 (Ac-225) – a highly promising and precise substance that targets cancer cells while sparing healthy tissue. With our trusted expertise and innovative spirit, we are taking an important step toward a large-scale, reliable supply of this rare isotope to enable innovative treatments and bring new hope to cancer patients worldwide.